MedTrace Logo

Prospective Study of Thoracolumbar Spinal Fusion Graft

NCT02297256 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2026-04-30

Study results available
· View outcomes & findings →

Summary

This study is a single-center, prospective randomized clinical study intended to compare and evaluate the efficacy of subjects who are treated with bone marrow aspirate concentrate (BMAC) and allograft to iliac crest bone grafts (ICBG) during posterior lumbar/lumbosacral spinal fusion.

Conditions

  • Lumbar Degenerative Disc Disease

Interventions

PROCEDURE

BMAC & Allograft

Use of Allograft infused with adult stem cells from the bone marrow aspirate harvested from the iliac crest during posterior lumbar/lumbosacral spinal fusion.

PROCEDURE

Iliac Crest Bone Graft

Use of iliac crest bone grafts (ICBG) during posterior lumbar/lumbosacral spinal fusion.

Sponsors & Collaborators

Principal Investigators

  • Peter Passias, MD · NYU School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-24
Primary Completion
2018-11-30
Completion
2020-11-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02297256 on ClinicalTrials.gov